Drug Profile
Formoterol/fluticasone propionate - Dey
Alternative Names: Fluticasone propionate/formoterol - DeyLatest Information Update: 18 Dec 2020
Price :
$50
*
At a glance
- Originator Dey LP
- Developer Mylan
- Class Antiallergics; Antiasthmatics; Ethanolamines; Glucocorticoids; Small molecules
- Mechanism of Action Beta 2 adrenergic receptor agonists; Steroid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Suspended Chronic obstructive pulmonary disease
Most Recent Events
- 02 Feb 2015 Suspended - Phase-II for Chronic obstructive pulmonary disease in USA (Inhalation)
- 02 Feb 2015 Suspended - Phase-III for Chronic obstructive pulmonary disease (In the elderly, In adults) in Hungary, Belgium, Slovakia, Sweden and Denmark (Inhalation)
- 06 Nov 2014 Phase-III clinical trials in Chronic obstructive pulmonary disease (In the elderly, In adults) in Belgium (Inhalation)